Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J7OM
|
||||
| Former ID |
DNC008099
|
||||
| Drug Name |
6-(benzylamino)-9-butyl-9H-purine-2-carbonitrile
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529240] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C17H18N6
|
||||
| Canonical SMILES |
CCCCN1C=NC2=C1N=C(N=C2NCC3=CC=CC=C3)C#N
|
||||
| InChI |
1S/C17H18N6/c1-2-3-9-23-12-20-15-16(21-14(10-18)22-17(15)23)19-11-13-7-5-4-6-8-13/h4-8,12H,2-3,9,11H2,1H3,(H,19,21,22)
|
||||
| InChIKey |
OJVVVZACBFLFEJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | Inhibitor | [529240] | |
| NetPath Pathway | IL4 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.